Pregabablin Open-Label, Follow-On Safety Trial In Patients With Refractory Partial Epilepsy.
Pregabablin Open-Label, Follow-On Safety Trial In Patients With Refractory Partial Epilepsy.
To evaluate the long-term safety of pregabalin in refractory partial epilepsy.
Inclusion Criteria:
Exclusion Criteria: